Cargando…
SpyGlass DS-guided lithotripsy for pancreatic duct stones in symptomatic treatment-refractory chronic calcifying pancreatitis
Background and study aims Endoscopic retrograde cholangiopancreatography (ERCP) and/or extracorporeal shock wave lithotripsy are first-line therapies for draining an obstructed pancreatic duct (PD) in painful chronic calcifying pancreatitis (CCP). Pancreaticoscopy has shown promising success rates...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
© Georg Thieme Verlag KG
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336461/ https://www.ncbi.nlm.nih.gov/pubmed/30705939 http://dx.doi.org/10.1055/a-0808-4499 |
_version_ | 1783388059690074112 |
---|---|
author | Gerges, Christian Pullmann, David Bahin, Farzan Schneider, Markus Siersema, Peter D. Neuhaus, Horst van Geenen, Erwin-Jan M. Beyna, Torsten |
author_facet | Gerges, Christian Pullmann, David Bahin, Farzan Schneider, Markus Siersema, Peter D. Neuhaus, Horst van Geenen, Erwin-Jan M. Beyna, Torsten |
author_sort | Gerges, Christian |
collection | PubMed |
description | Background and study aims Endoscopic retrograde cholangiopancreatography (ERCP) and/or extracorporeal shock wave lithotripsy are first-line therapies for draining an obstructed pancreatic duct (PD) in painful chronic calcifying pancreatitis (CCP). Pancreaticoscopy has shown promising success rates in small series. Materials and methods This study was a retrospective analysis of a clinical database. Included were all digital single-operator digital video (SOV) pancreaticoscopy-guided interventions (n = 23) on CCP patients (n = 20) between 2015 and 2017. Success and complication rates were collected from the database. Clinical success was determined by assessing pain level score (NRS) and quality of life (QoL) using standardized questionnaires. Results Overall technical success rate (successful SOV-pancreaticoscopy and PD drainage) was 95 %. Adverse events occurred in 7 of 23 procedures (30 %) and included extravasation from the PD (n = 1), self-limiting post-sphincterotomy bleeding (n = 1) and post-ERCP pancreatitis (PEP) (n = 6). At 3- to 6-month follow-up, 95 % of patients reported improvement in symptoms and reduction in intake of analgesics. Mean NRS decreased from 5.4 (±1.6) to 2.8 (± 1.8) ( P < 0.01). Clinical success was achieved in 95 % of patients. Conclusions Digital SOV-guided lithotripsy was found to be safe and effective in this highly selected population of CCP patients. PD decompression had a beneficial effect on pain reduction and QoL. |
format | Online Article Text |
id | pubmed-6336461 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | © Georg Thieme Verlag KG |
record_format | MEDLINE/PubMed |
spelling | pubmed-63364612019-02-01 SpyGlass DS-guided lithotripsy for pancreatic duct stones in symptomatic treatment-refractory chronic calcifying pancreatitis Gerges, Christian Pullmann, David Bahin, Farzan Schneider, Markus Siersema, Peter D. Neuhaus, Horst van Geenen, Erwin-Jan M. Beyna, Torsten Endosc Int Open Background and study aims Endoscopic retrograde cholangiopancreatography (ERCP) and/or extracorporeal shock wave lithotripsy are first-line therapies for draining an obstructed pancreatic duct (PD) in painful chronic calcifying pancreatitis (CCP). Pancreaticoscopy has shown promising success rates in small series. Materials and methods This study was a retrospective analysis of a clinical database. Included were all digital single-operator digital video (SOV) pancreaticoscopy-guided interventions (n = 23) on CCP patients (n = 20) between 2015 and 2017. Success and complication rates were collected from the database. Clinical success was determined by assessing pain level score (NRS) and quality of life (QoL) using standardized questionnaires. Results Overall technical success rate (successful SOV-pancreaticoscopy and PD drainage) was 95 %. Adverse events occurred in 7 of 23 procedures (30 %) and included extravasation from the PD (n = 1), self-limiting post-sphincterotomy bleeding (n = 1) and post-ERCP pancreatitis (PEP) (n = 6). At 3- to 6-month follow-up, 95 % of patients reported improvement in symptoms and reduction in intake of analgesics. Mean NRS decreased from 5.4 (±1.6) to 2.8 (± 1.8) ( P < 0.01). Clinical success was achieved in 95 % of patients. Conclusions Digital SOV-guided lithotripsy was found to be safe and effective in this highly selected population of CCP patients. PD decompression had a beneficial effect on pain reduction and QoL. © Georg Thieme Verlag KG 2019-02 2019-01-17 /pmc/articles/PMC6336461/ /pubmed/30705939 http://dx.doi.org/10.1055/a-0808-4499 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited. |
spellingShingle | Gerges, Christian Pullmann, David Bahin, Farzan Schneider, Markus Siersema, Peter D. Neuhaus, Horst van Geenen, Erwin-Jan M. Beyna, Torsten SpyGlass DS-guided lithotripsy for pancreatic duct stones in symptomatic treatment-refractory chronic calcifying pancreatitis |
title | SpyGlass DS-guided lithotripsy for pancreatic duct stones in symptomatic treatment-refractory chronic calcifying pancreatitis |
title_full | SpyGlass DS-guided lithotripsy for pancreatic duct stones in symptomatic treatment-refractory chronic calcifying pancreatitis |
title_fullStr | SpyGlass DS-guided lithotripsy for pancreatic duct stones in symptomatic treatment-refractory chronic calcifying pancreatitis |
title_full_unstemmed | SpyGlass DS-guided lithotripsy for pancreatic duct stones in symptomatic treatment-refractory chronic calcifying pancreatitis |
title_short | SpyGlass DS-guided lithotripsy for pancreatic duct stones in symptomatic treatment-refractory chronic calcifying pancreatitis |
title_sort | spyglass ds-guided lithotripsy for pancreatic duct stones in symptomatic treatment-refractory chronic calcifying pancreatitis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336461/ https://www.ncbi.nlm.nih.gov/pubmed/30705939 http://dx.doi.org/10.1055/a-0808-4499 |
work_keys_str_mv | AT gergeschristian spyglassdsguidedlithotripsyforpancreaticductstonesinsymptomatictreatmentrefractorychroniccalcifyingpancreatitis AT pullmanndavid spyglassdsguidedlithotripsyforpancreaticductstonesinsymptomatictreatmentrefractorychroniccalcifyingpancreatitis AT bahinfarzan spyglassdsguidedlithotripsyforpancreaticductstonesinsymptomatictreatmentrefractorychroniccalcifyingpancreatitis AT schneidermarkus spyglassdsguidedlithotripsyforpancreaticductstonesinsymptomatictreatmentrefractorychroniccalcifyingpancreatitis AT siersemapeterd spyglassdsguidedlithotripsyforpancreaticductstonesinsymptomatictreatmentrefractorychroniccalcifyingpancreatitis AT neuhaushorst spyglassdsguidedlithotripsyforpancreaticductstonesinsymptomatictreatmentrefractorychroniccalcifyingpancreatitis AT vangeenenerwinjanm spyglassdsguidedlithotripsyforpancreaticductstonesinsymptomatictreatmentrefractorychroniccalcifyingpancreatitis AT beynatorsten spyglassdsguidedlithotripsyforpancreaticductstonesinsymptomatictreatmentrefractorychroniccalcifyingpancreatitis |